EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Efficacy of Food Supplement Based on Monacolins, γ-Oryzanol, and γ-Aminobutyric Acid in Mild Dyslipidemia: A Randomized, Double-Blind, Parallel-Armed, Placebo-Controlled Clinical Trial

Lorenza Francesca De Lellis, Maria Vittoria Morone iD, Daniele Giuseppe Buccato, Marcello Cordara, Danaè S Larsen, Hammad Ullah iD, Roberto Piccinocchi, Gaetano Piccinocchi iD, Paulraj Balaji iD, Alessandra Baldi iD, Alessandro Di Minno iD, Hesham R El-Seedi iD und 2 weitere

Nutrients · 2024

DOI: 10.3390/nu16172983 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Lorenza Francesca De Lellis und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Naples "Federico II", Via D. Montesano 49, 80131 Naples, Italy. Hauptthemen laut MEDLINE: Dietary Supplements, Dyslipidemias, gamma-Aminobutyric Acid, Phenylpropionates. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The risk of cardiovascular disease (CVD) is approximately doubled in subjects with hypercholesterolemia compared to those with normal blood cholesterol levels. Monacolin K (MK), the main active substance in rice fermented by the Monascus purpureus, acts on cholesterol metabolism. Rice also contains other bioactive compounds such as γ-oryzanol (OZ) and γ-aminobutyric acid (GABA). In a randomized, placebo-controlled, double-blind trial, the efficacy and tolerability of a food supplement (FS) based on an ingredient standardized to contain monacolins (4.5%), OZ, and GABA were evaluated in subjects with mild dyslipidemia. For the duration of the trial, enrolled subjects (n = 44, each group) received the FS or placebo and were instructed to use an isocaloric diet. Compared to the placebo group, after a 3 months of the FS, the mean low-density lipoprotein cholesterol and mean TC values were reduced by 19.3 and 8.3%, respectively, while the mean high-density lipoprotein cholesterol value increased by 29.3%. On average, the subjects shifted from very high to moderate CVD risk. Glucose metabolism and hepatic and renal parameters did not change after the treatment and no adverse events were reported. Guidelines to handle hypercholesterolemia with food supplements in specific clinical settings are needed to better manage mild dyslipidemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dietary SupplementsDyslipidemiasgamma-Aminobutyric AcidPhenylpropionatesNaphthalenesAdultFemaleHumansMaleMiddle AgedCholesterol, HDLCholesterol, LDLDouble-Blind MethodLovastatinTreatment Outcome

Stichwörter der Autor:innen

mild dyslipidemiamonacolin Krandomized clinical trialred yeast riceγ-aminobutyric acidγ-oryzanol

Substanzen

Cholesterol, HDLCholesterol, LDLgamma-Aminobutyric Acidgamma-oryzanolLovastatinPhenylpropionatesNaphthalenes

Autor:innen und Institutionen

  • Department of Pharmacy, University of Naples "Federico II", Via D. Montesano 49, 80131 Naples, Italy.
  • Department of Experimental Medicine, Section of Microbiology and Clinical Microbiology, University of Campania "L. Vanvitelli", 80138 Naples, Italy.
  • School of Medicine, University of Milano-Bicocca, 20126 Milan, Italy.
  • School of Chemical Sciences, The University of Auckland, Auckland 1010, New Zealand.
  • Level 1 Medical Director Anaesthesia and Resuscitation A. U. O. Luigi Vanvitelli, Via Santa Maria di Costantinopoli, 80138 Naples, Italy.
  • Comegen S.c.S., Società Cooperativa Sociale di Medici di Medicina Generale, Viale Maria Bakunin 41, 80125 Naples, Italy.

ORCID-Profile: Maria Vittoria Morone, Hammad Ullah, Gaetano Piccinocchi, Paulraj Balaji, Alessandra Baldi, Alessandro Di Minno, Hesham R El-Seedi, Roberto Sacchi, Maria Daglia

Zitieren

APA

De Lellis, L. F., Morone, M. V., Buccato, D. G., Cordara, M., Larsen, D. S., Ullah, H., Piccinocchi, R., Piccinocchi, G., Balaji, P., Baldi, A., Di Minno, A., El-Seedi, H. R., Sacchi, R., & Daglia, M. (2024). Efficacy of Food Supplement Based on Monacolins, γ-Oryzanol, and γ-Aminobutyric Acid in Mild Dyslipidemia: A Randomized, Double-Blind, Parallel-Armed, Placebo-Controlled Clinical Trial. Nutrients. https://doi.org/10.3390/nu16172983

Vancouver

De Lellis LF, Morone MV, Buccato DG, Cordara M, Larsen DS, Ullah H, et al. Efficacy of Food Supplement Based on Monacolins, γ-Oryzanol, and γ-Aminobutyric Acid in Mild Dyslipidemia: A Randomized, Double-Blind, Parallel-Armed, Placebo-Controlled Clinical Trial. Nutrients. 2024. doi:10.3390/nu16172983

BibTeX
@article{DeLellis2024,
  author = {De Lellis, Lorenza Francesca and Morone, Maria Vittoria and Buccato, Daniele Giuseppe and Cordara, Marcello and Larsen, Danaè S and Ullah, Hammad and Piccinocchi, Roberto and Piccinocchi, Gaetano and Balaji, Paulraj and Baldi, Alessandra and Di Minno, Alessandro and El-Seedi, Hesham R and Sacchi, Roberto and Daglia, Maria},
  title = {Efficacy of Food Supplement Based on Monacolins, γ-Oryzanol, and γ-Aminobutyric Acid in Mild Dyslipidemia: A Randomized, Double-Blind, Parallel-Armed, Placebo-Controlled Clinical Trial},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16172983}
}
Kostenlos starten →